homovanillic acid has been researched along with Epilepsies, Myoclonic in 6 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Epilepsies, Myoclonic: A clinically diverse group of epilepsy syndromes characterized either by myoclonic seizures or by myoclonus in association with other seizure types. Myoclonic epilepsy syndromes are divided into three subtypes based on etiology: familial, cryptogenic, and symptomatic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The degenerative type of progressive myoclonus epilepsy (PME) is a hereditary disease with grand mal seizures, stimulus sensitive myoclonus, characteristic EEG and mental deterioration in the late stage." | 1.26 | Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA. ( Airaksinen, EM; Leino, E, 1982) |
| "The neurochemical basis of myoclonus responding to 5HT precursors and clonazepam is discussed." | 1.26 | Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. ( Chadwick, D; Hallett, M; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leino, E | 3 |
| MacDonald, E | 2 |
| Airaksinen, MM | 2 |
| Riekkinen, PJ | 3 |
| Salo, H | 1 |
| Airaksinen, EM | 2 |
| Chadwick, D | 1 |
| Hallett, M | 1 |
| Harris, R | 1 |
| Jenner, P | 1 |
| Reynolds, EH | 1 |
| Marsden, CD | 1 |
| Kimiya, S | 1 |
| Seki, T | 1 |
| Maezawa, M | 1 |
| Yamada, T | 1 |
| Tachibana, Y | 1 |
| Koivisto, K | 1 |
| Keränen, T | 1 |
| Pitkänen, A | 1 |
| Oja, SS | 1 |
| Marnela, KM | 1 |
| Partanen, JV | 1 |
| Tokola, O | 1 |
| Gothóni, G | 1 |
2 trials available for homovanillic acid and Epilepsies, Myoclonic
| Article | Year |
|---|---|
L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy.
Topics: Blood Platelets; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Epilepsies, Myoclon | 1981 |
Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.
Topics: Adult; Amino Acids; Anticonvulsants; Clinical Trials as Topic; Epilepsies, Myoclonic; Epilepsies, Pa | 1987 |
4 other studies available for homovanillic acid and Epilepsies, Myoclonic
| Article | Year |
|---|---|
Homovanillic acid and 5-hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with progressive myoclonus epilepsy.
Topics: Adult; Brain; Epilepsies, Myoclonic; Female; Finland; Homovanillic Acid; Humans; Hydroxyindoleacetic | 1980 |
Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA.
Topics: Adult; Epilepsies, Myoclonic; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyind | 1982 |
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzodiazepinones; Carbidopa; Child, Preschool; Clonaz | 1977 |
Analysis of monamine metabolism in cerebrospinal fluid in childhood epilepsies.
Topics: Adolescent; Brain Damage, Chronic; Child; Child, Preschool; Epilepsies, Myoclonic; Epilepsy; Epileps | 1989 |